"[21B54B5D706C]" . "CZ - \u010Cesk\u00E1 republika" . . . . "Mo\u017Enosti vyu\u017Eit\u00ED n\u011Bkter\u00FDch peror\u00E1ln\u00EDch antidiabetik v adjuvantn\u00ED l\u00E9\u010Db\u011B diabetik\u016F 1. typu" . "\u0160mahelov\u00E1, Alena" . . . "The potential of some oral anti-diabetic drugs for use as andjuvant therapy in type 1 diabetic patients"@en . . "http://www.remedia.cz/Archiv-rocniku/Rocnik-2011/1-2011/Moznosti-vyuziti-nekterych-peroralnich-antidiabetik-v-adjuvantni-lecbe-diabetiku-1-typu/e-ZK-ZN-11M.magarticle.aspx" . . "RIV/00216208:11160/11:10103919" . "P\u0159ehled recentn\u00EDch informac\u00ED publikovan\u00FDch studi\u00ED, kter\u00E9 se zab\u00FDvaj\u00ED efektivitou a bezpe\u010Dnost\u00ED pod\u00E1v\u00E1n\u00ED peror\u00E1ln\u00EDch antidiabetik jako adjuvantn\u00ED l\u00E9\u010Dby diabetik\u016F 1. typu. Nejv\u00EDce d\u016Fkaz\u016F pro adjuvatn\u00ED l\u00E9\u010Dbu diabetik\u016F 1. typu m\u00E1 metformin."@cs . . "7"^^ . . . "2"^^ . "P\u0159ehled recentn\u00EDch informac\u00ED publikovan\u00FDch studi\u00ED, kter\u00E9 se zab\u00FDvaj\u00ED efektivitou a bezpe\u010Dnost\u00ED pod\u00E1v\u00E1n\u00ED peror\u00E1ln\u00EDch antidiabetik jako adjuvantn\u00ED l\u00E9\u010Dby diabetik\u016F 1. typu. Nejv\u00EDce d\u016Fkaz\u016F pro adjuvatn\u00ED l\u00E9\u010Dbu diabetik\u016F 1. typu m\u00E1 metformin." . "3"^^ . "11160" . . . . . . "0862-8947" . "S" . "RIV/00216208:11160/11:10103919!RIV12-MSM-11160___" . "Mo\u017Enosti vyu\u017Eit\u00ED n\u011Bkter\u00FDch peror\u00E1ln\u00EDch antidiabetik v adjuvantn\u00ED l\u00E9\u010Db\u011B diabetik\u016F 1. typu"@cs . "21" . "214082" . "Hendrychov\u00E1, Tereza" . "Remedia" . "Mo\u017Enosti vyu\u017Eit\u00ED n\u011Bkter\u00FDch peror\u00E1ln\u00EDch antidiabetik v adjuvantn\u00ED l\u00E9\u010Db\u011B diabetik\u016F 1. typu" . "1" . "The potential of some oral anti-diabetic drugs for use as andjuvant therapy in type 1 diabetic patients"@en . "Overview of recently published studies concerning the effcacy and safety of oral anti-diabetic drugs as adjuvant therapy in type 1 diabetes mellitus. From the overview it follows that most important body of evidence is available for use of metformin as adjuvant therapy in type 1 diabetes mellitus."@en . "acarbose; sulphonylureas; incretin therapy; thiazolidinediones; metformin; type 1 diabetes mellitus"@en . . . . . "Vl\u010Dek, Ji\u0159\u00ED" . "Mo\u017Enosti vyu\u017Eit\u00ED n\u011Bkter\u00FDch peror\u00E1ln\u00EDch antidiabetik v adjuvantn\u00ED l\u00E9\u010Db\u011B diabetik\u016F 1. typu"@cs .